FDA Cleared vs FDA Approved: What You Can Legally Say in Your Medical Device Marketing

The distinction sounds like legal fine print. It is not. The FDA actively enforces the line between these two terms, and the consequences range from a public warning letter to product seizure. If your device went through 510(k), your website, your sales deck, and your LinkedIn posts all need to say "cleared," not "approved." Here is what each term means, which pathway earns it, and how to check your copy before it goes live.

What Is the Difference Between FDA Cleared and FDA Approved?

The two terms describe two different regulatory outcomes from two different review processes.

FDA cleared means the FDA reviewed your premarket notification (510(k)) and concluded that your device is substantially equivalent to a legally marketed predicate device. The agency does not independently evaluate whether the device is safe and effective in an absolute sense. It asks whether the device is at least as safe and effective as the predicate. Clearance is the dominant pathway for Class II devices: glucose meters, infusion pumps, ultrasound systems, diagnostic software, and thousands of others.

FDA approved means the FDA reviewed a Premarket Approval application (PMA) and independently determined that the device is safe and effective for its intended use. PMA is the highest standard of regulatory review. It is required for Class III devices: implantable pacemakers, cochlear implants, mechanical heart valves, and other high-risk devices without a cleared predicate.

The distinction matters because "clearance" and "approval" represent fundamentally different levels of regulatory review, and 21 CFR 807.97 makes that explicit. The regulation states that a substantial equivalence determination "does not in any way denote official approval of the device," and that "any representation that creates an impression of official approval of a device because of complying with the premarket notification regulations is misleading and constitutes misbranding."

The misbranding prohibition runs through the Federal Food, Drug, and Cosmetic Act itself. Section 502(a) (21 U.S.C. 352) declares a device misbranded if its labeling is false or misleading in any particular, and FDA guidance confirms that promotional materials, websites, and sales presentations all count as labeling for enforcement purposes.

What About De Novo Devices? (The "Granted" Pathway)

There is a third marketing authorization pathway that sits between 510(k) and PMA: the De Novo classification request. It applies to novel, low-to-moderate-risk devices that have no predicate device and therefore cannot reach the market via 510(k).

When the FDA grants a De Novo request, the device is neither "cleared" nor "approved." The correct term is "granted" (sometimes written as "De Novo granted" or "received De Novo authorization"). FDA's own De Novo page describes the outcome as receiving a "De Novo classification order." Using "cleared" or "approved" for a De Novo device is the same category of error as calling a cleared device approved.

The Four Pathways and Their Correct Marketing Terms

For exempt devices, the safest approach is to describe the regulatory status accurately ("this device is a Class I exempt medical device") rather than claim any form of FDA endorsement.

Phrases That Are Safe vs. Phrases That Create Risk

The following guidance reflects the FDA's own language and documented enforcement posture (as of July 2026). This is not an exhaustive list, and your regulatory counsel should review every marketing claim.

Safe phrases for 510(k) devices

• "FDA cleared"
• "510(k) cleared"
• "cleared by the FDA for [intended use]"
• "received 510(k) clearance from the FDA"

Phrases that create misbranding risk for 510(k) devices

• "FDA approved" (the most common violation)
• "approved by the FDA"
• "FDA certified" (see section below)
• "FDA validated"
• Any visual use of the FDA logo or seal in promotional materials (the FDA logo is for official government use, not private-sector use)

Safe phrases for PMA devices

• "FDA approved"
• "received Premarket Approval from the FDA"
• "PMA-approved"

Safe phrases for De Novo devices

• "FDA De Novo authorized"
• "received De Novo classification from the FDA"
• "granted De Novo status by the FDA"

Platform-specific notes

Website copy: The violation most often cited in warning letters is a product page or homepage banner stating "FDA Approved" for a cleared device. Review every page where regulatory status appears.

LinkedIn: Posts and company page descriptions follow the same rules as advertising. "FDA approved" in a LinkedIn post about a 510(k) device is the same risk as on your website.

Sales decks: Slides presented to hospital procurement teams or distributors count as promotional materials. A slide deck heading that reads "FDA Approvals" for a list of your cleared devices is a documented violation pattern.

Press releases: Publicly distributed press releases are promotional labeling. Apply the same standard.

The "FDA Registered" and "FDA Certified" Traps

Two phrases appear constantly in device marketing, and both are misleading as promotional claims.

"FDA registered" describes a facility that has met the establishment registration requirement under 21 U.S.C. 360. It is not a marketing authorization. It does not mean the device has been reviewed or cleared. The FDA's own consumer guidance page is explicit: when a facility registers its establishment and lists its devices, "the resulting entry in the FDA's registration and listing database does not denote approval, clearance, or authorization of that facility or its medical devices." The parallel misbranding provision, 21 CFR 807.39, states that "any representation that creates an impression of official approval because of registration or possession of a registration number is misleading and constitutes misbranding." Using "FDA registered" as a marketing claim, particularly in a way that implies FDA review of the device itself, falls squarely within that prohibition.

"FDA certified" does not exist as a device designation. The FDA does not issue certificates or certifications for medical devices or facilities. The agency's consumer page cited above states that it "does not issue any type of device registration certificates to medical device facilities." A device company claiming to be "FDA certified" is either confused or creating a false impression of endorsement.

Neither phrase belongs in marketing copy as a badge of credibility. If you need to disclose registration status for transparency, do it accurately: "Our manufacturing facility is FDA registered." Nothing more.

Two Enforcement Patterns Worth Knowing

The registration-and-logo pattern. In March 2021, the FDA sent letters to 25 firms asking them to stop producing and issuing misleading "FDA Registration Certificates" to medical device companies. Many of these certificates were designed to look like official government documents, and some displayed the FDA logo, creating what the FDA described as the misimpression that the agency had reviewed, approved, cleared, or authorized the products. The FDA was direct about the underlying facts: it "does not issue any type of registration certificates to medical device establishments," and a registration-and-listing database entry "does not denote approval, clearance, or authorization of that facility or its medical devices." (See FDA in Brief.) This is the clearest recent illustration of why "FDA registered," "FDA certified," and the FDA logo do not belong in marketing as endorsements.

The modification pattern. A second, less obvious trap is changing a cleared device without asking whether the change requires a new 510(k). In its June 12, 2023 warning letter to Vitang Technology LLC, maker of the 510(k)-cleared UniSmile Clear Aligner System, the FDA cited the company for changing the software used to develop treatment plans (from the cleared software to a different, non-cleared package) without submitting a new 510(k), along with quality system regulation violations under 21 CFR Part 820. (Warning letter indexed at fda.gov.) The marketing lesson is indirect but important: your clearance covers the device as cleared. Material changes can move the device outside that clearance, which in turn affects what you can accurately say about its regulatory status.

Taken together, these patterns show that regulatory-status accuracy is not only about the word "approved." It also covers registration-based claims, logo use, and whether the device you are marketing is still the device that was cleared.

Off-Label Promotion Basics

Even when your language about clearance status is correct, your claims can still create regulatory problems if they exceed the device's cleared indications for use.

Under 21 CFR Part 801, device labeling (including promotional materials) must be consistent with the intended use established in the 510(k). When a company promotes a device for a use not covered by its clearance, the FDA's traditional position is that the promotion can establish a new intended use, which in turn can render the device misbranded (its labeling no longer matches its marketed use) or adulterated (a new intended use may require a clearance or approval the device does not have). The precise boundaries of permissible manufacturer communication are an active and evolving area of law, so this is territory where your regulatory counsel should be involved directly rather than relying on general rules.

Practical guidance for marketing teams:

• Keep a copy of your 510(k) clearance letter and the cleared intended use statement. Post it somewhere the marketing team can access it.
• Every new marketing claim should be compared against that intended use statement before it is published.
• "Intended use" and "indications for use" are related but technically distinct in FDA terminology. Your regulatory team should define the boundary for marketing.
• If your clinical evidence supports a broader use, the right path is a new 510(k) or a PMA supplement, not broader marketing copy.

The FDA's general device labeling requirements page and the labeling misbranding page are the starting points for understanding what labeling must and must not contain.

Pre-Publish Claims Checklist for Marketing Teams

Run every piece of marketing content through this checklist before it goes live.

Regulatory status language

• Does the copy accurately reflect the pathway (cleared/approved/De Novo granted/exempt)?
• Does any copy use "approved" for a 510(k) or De Novo device? (If yes, revise.)
• Does any copy use "FDA certified," "FDA validated," or "FDA endorsed"? (None of these are real designations; revise.)
• Does any copy use "FDA registered" as a product-quality signal rather than a factual facility disclosure? (Revise if so.)
• Does the FDA logo or seal appear anywhere in the materials? (Remove; the FDA logo is for official government use, not private-sector marketing.)

Intended use boundary

• Have all performance claims been compared against the cleared/approved intended use?
• Are there any claims about patient populations, anatomical sites, or conditions not covered by the cleared/approved indications?
• Have any new clinical findings or applications been reviewed by regulatory counsel before appearing in copy?

General accuracy

• Are regulatory status claims date-stamped or otherwise tied to current clearance status?
• If the device has been modified since clearance, has it been confirmed that no new 510(k) is required?

One Final Note on Getting This Right

The gap between regulatory knowledge and marketing execution is where most device companies get into trouble. Marketers under launch pressure want to lead with their strongest credential. Regulatory teams often cannot review every social post and sales deck revision in real time. The result is "FDA Approved" appearing in places where "FDA Cleared" belongs, usually with no intent to mislead and real legal exposure regardless.

Buzzbox Media works exclusively with medical device and healthcare companies. Our content and marketing process includes a regulatory claims review step, so what goes out the door has been compared against cleared indications before it goes live. If you are six to twelve months from launch and want to build a marketing program that holds up under FDA scrutiny, a 30-minute call is a reasonable starting point. Learn more about our medical device marketing services or book at https://www.buzzboxmedia.com/book.

Sources Cited

• 21 CFR 807.97 (Misbranding by reference to premarket notification): https://www.law.cornell.edu/cfr/text/21/807.97
• 21 CFR 807.39 (Misbranding by reference to establishment registration): https://www.law.cornell.edu/cfr/text/21/807.39
• 21 U.S.C. 352 (FD&C Act section 502, misbranded drugs and devices): https://uscode.house.gov/view.xhtml?req=(title:21+section:352+edition:prelim)
• FDA, De Novo Classification Request: https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/de-novo-classification-request
• FDA, General Device Labeling Requirements: https://www.fda.gov/medical-devices/device-labeling/general-device-labeling-requirements
• FDA, Labeling Requirements Regarding Misbranding: https://www.fda.gov/medical-devices/general-device-labeling-requirements/labeling-requirements-misbranding
• FDA, Warning Letter: Vitang Technology LLC #653455, June 12, 2023: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vitang-technology-llc-653455-06122023
• FDA consumer page on FDA registered/certified claims: https://www.fda.gov/medical-devices/consumers-medical-devices/are-there-fda-registered-or-fda-certified-medical-devices-how-do-i-know-what-fda-approved
• FDA in Brief: FDA Calls on Certain Firms to Stop Producing and Issuing Misleading "FDA Registration Certificates" (March 2021): https://www.fda.gov/news-events/fda-brief/fda-brief-fda-calls-certain-firms-stop-producing-and-issuing-misleading-fda-registration
• FDA Name and Logo Policy: https://www.fda.gov/about-fda/website-policies/fda-name-and-logo-policy
• FDA, How to Study and Market Your Device: https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/how-study-and-market-your-device